Date:
Mon, 22 Jun 2026 09:29:48 EDT
Content:
The U.S. Food and Drug Administration (FDA) has issued a Form 483 to Pharmaneek Inc. following an inspection of their facility located in Indianapolis, Indiana. The document, dated April 8, 2026, highlights observations made by investigators regarding the company’s manufacturing practices.
Pharmaneek Inc. is identified as a producer of non-sterile drug products. An FDA Form 483 is typically issued at the conclusion of an inspection when agency investigators have observed conditions that may constitute violations of the Food, Drug, and Cosmetic Act and related regulations.
The issuance of this report indicates that specific concerns were identified regarding the site’s quality control or production processes. The company is now required to address these observations and provide the FDA with a formal plan for corrective actions to ensure compliance with federal standards.
Source: FDA Electronic Reading Room
Link:
http://www.fda.gov/about-fda/fda-commissioner/pharmaneek-inc-indianapolis-483-issued-04082026
Keywords:
FDA Form 483, Pharmaneek Inc, Indianapolis, pharmaceutical inspection, non-sterile drug products, FDA compliance